Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 3,558 | 23,662 | 3,755 | 3,502 | 3,692 |
| Gross Profit | 3,558 | 23,662 | 3,755 | 3,502 | 3,692 |
| Operating Expenses | 41,000 | 38,295 | 36,623 | 34,618 | 34,270 |
| Operating Income | -37,442 | -14,633 | -32,868 | -31,116 | -30,578 |
| Other Income | 3,130 | 4,631 | 3,349 | 3,072 | 3,659 |
| Pre-tax Income | -34,312 | -10,002 | -29,519 | -28,044 | -26,919 |
| Net Income Continuous | -34,505 | -10,002 | -29,519 | -28,044 | -26,989 |
| Net Income | $-34,505 | $-10,002 | $-29,519 | $-28,044 | $-26,989 |
| EPS Basic Total Ops | -0.32 | -0.12 | -0.48 | -0.46 | -0.44 |
| EPS Basic Continuous Ops | -0.32 | -0.12 | -0.48 | -0.46 | -0.44 |
| EPS Diluted Total Ops | -0.32 | -0.12 | -0.48 | -0.46 | -0.44 |
| EPS Diluted Continuous Ops | -0.32 | -0.12 | -0.48 | -0.46 | -0.44 |
| EBITDA(a) | $-35,085 | $-15,498 | $-34,355 | $-32,021 | $-30,975 |